ArticleJournal of clinical medicine2022

Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.

Brian R Peine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.